CBD and Lyme Disease: What You Need to Know

Apr 30, 2026 11:00AM ● By Valerie Aloisio

By firman on AdobeStock.com

Lyme disease, a tick-borne illness caused by the bacterium Borrelia burgdorferi, can result in a range of symptoms, including fatigue, joint pain and neurological issues. As the search for effective treatments continues, some individuals have turned to CBD (cannabidiol) for symptom relief. In this short article, we will discuss what you need to know about using CBD for Lyme disease and its potential benefits.

CBD, a nonpsychoactive compound found in the Cannabis sativa plant, interacts with the body’s endocannabinoid system (ECS), which plays a crucial role in maintaining balance and regulating various functions, including pain, inflammation and immune response. Emerging research suggests that imbalances in this system—called clinical endocannabinoid deficiency—may be at the root of many inflammation-related, neurological and immune disorders.

Back in 2003, U.S. Patent No. 6,630,507 was granted by the Patent and Trademark Office, titled Cannabinoids as Antioxidants and Neuroprotectants. This discovery suggests cannabinoids may be useful in the treatment and prevention of a wide variety of oxidation-associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases. The cannabinoids have been found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic events, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease and HIV dementia.

CBD and Lyme Diseases – Potential Benefits:

While CBD is not a cure for Lyme disease, it is frequently used as a supportive therapy to manage symptoms and complications associated with the infection and post-treatment Lyme disease syndrome (PTLDS).

1. Neuroprotective effects: In some cases, Lyme disease can cause neurological issues, such as cognitive impairment and nerve pain. CBD has exhibited neuroprotective properties in various studies, which may help protect the nervous system and reduce symptoms.

2. Pain management: CBD’s analgesic properties can help alleviate joint and muscle aches, common in both early and late-stage Lyme disease.

3. Anti-inflammatory properties: Inflammation is a critical component of Lyme disease, contributing to many symptoms. CBD’s anti-inflammatory properties may help reduce inflammation, potentially providing relief.

4. Sleep and anxiety: Many patients report relief from insomnia and anxiety. CBD has demonstrated potential benefits for sleep regulation, which may help improve sleep quality, reduce fatigue and anxiety and improve cognitive function.

5. Immune system support: CBD may help modulate the immune system, potentially aiding the body in fighting the Lyme-causing bacteria. However, more research is needed to fully understand the relationship between CBD and immune function in the context of Lyme disease.

6. Antibacterial potential: While antibiotics remain the primary treatment, some studies suggest certain cannabinoids, including CBD, may have antibacterial properties that could assist against the Lyme disease bacterium Borrelia burgdorferi.

Using CBD for Lyme Disease

When considering CBD for Lyme disease symptom management, it is essential to choose a high-quality product and find the right dosage for your needs. Start with a low dose and gradually increase until you find the optimal amount to manage your symptoms. Remember that CBD should not replace conventional Lyme disease treatments, and it is crucial to consult a health care professional before incorporating CBD into your treatment plan.

Valerie Aloisio is founder of Hemp Lifestyle and a pioneer at bringing education and information about the endocannabinoid system and cannabinoid products to medical and healthcare professionals and the public in the U.S. and abroad. She is available for complimentary consultation, educational sessions and speaking engagements. Connect at 203-521-2396, [email protected] or HempLifestyle.net. See ad, page 13.